Intervention Protocol

Cyclosporine for maintenance of remission in Crohn's disease

  1. Jorn Brynskov2,
  2. Brian G Feagan1,
  3. Derek P Jewell3,
  4. John WD McDonald1,*,
  5. Eduard F Stange4

Editorial Group: Cochrane Inflammatory Bowel Disease and Functional Bowel Disorders Group

Published Online: 21 OCT 1996

DOI: 10.1002/14651858.CD000302

How to Cite

Brynskov J, Feagan BG, Jewell DP, McDonald JWD, Stange EF. Cyclosporine for maintenance of remission in Crohn's disease (Protocol). Cochrane Database of Systematic Reviews 1996, Issue 4. Art. No.: CD000302. DOI: 10.1002/14651858.CD000302.

Author Information

  1. 1

    Robarts Research Institute, Robarts Clinical Trials, London, Ontario, Canada

  2. 2

    Herlev University Hospital, Department of Medical Gastroenterology C, Copenhagen, Denmark

  3. 3

    Gibson Laboratories (2nd Floor), Gastroenterology Unit, OXFORD, UK

  4. 4

    Schwerpunkte Gastroenterologie, Hepatologie und Endokrinologie, Abteilung fur Innere Medizin 1, 70341 Stuttgart, Germany

*John WD McDonald, Robarts Clinical Trials, Robarts Research Institute, P.O. Box 5015, 100 Perth Drive, London, Ontario, N6A 5K8, Canada.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 21 OCT 1996




  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To evaluate the effectiveness of oral cyclosporin-A for maintenance of remission in patients with inactive Crohn's disease in the presence and absence of concomitant steroid therapy.

A secondary objective is to evaluate the toxicity of cyclosporin-A in patients with Crohn's disease.